Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna-Mart Engelbrecht

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Autophagy|April 14, 2009
Cell death: a dynamic response conceptBenjamin Loos, Anna-Mart Engelbrecht
Immunology Letters|February 21, 2015
On the evolutionary origin of the adaptive immune system--the adipocyte hypothesisGustav van Niekerk, Anna-Mart Engelbrecht
Journal of Toxicology|September 9, 2015
Circadian Rhythms and Breast Cancer: The Role of Per2 in Doxorubicin-Induced Cell DeathMegan I Mitchell, Anna-Mart Engelbrecht
Clinical Nutrition ESPEN|August 28, 2019
Evolutionary physiology shows the need for an unprecedented study on sugarGustav van Niekerk, Anna-Mart Engelbrecht
Frontiers in Microbiology|June 16, 2015
Commentary on: "A common origin for immunity and digestion"Gustav van Niekerk, Anna-Mart Engelbrecht
Cytokine & Growth Factor Reviews|July 5, 2018
Inflammation-induced metabolic derangements or adaptation: An immunometabolic perspectiveGustav van Niekerk, Anna-Mart Engelbrecht
Critical Reviews in Oncology/Hematology|December 25, 2016
Metabolic hijacking: A survival strategy cancer cells exploit?Megan I Mitchell, Anna-Mart Engelbrecht
Cellular Oncology (Dordrecht, Netherlands)|May 26, 2018
Role of PKM2 in directing the metabolic fate of glucose in cancer: a potential therapeutic targetGustav van Niekerk, Anna-Mart Engelbrecht
Future Oncology (London, England)|July 23, 2015
Melatonin: a protective role against doxorubicin-induced cardiotoxicityJenelle Govender, Ben Loos, Anna-Mart Engelbrecht
Cytokine|February 9, 2011
Tumor necrosis factor alpha (TNF-α) inactivates the PI3-kinase/PKB pathway and induces atrophy and apoptosis in L6 myotubesBalindiwe J N Sishi, Anna-Mart Engelbrecht
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Autophagy|April 14, 2009
Cell death: a dynamic response conceptBenjamin Loos, Anna-Mart Engelbrecht
Immunology Letters|February 21, 2015
On the evolutionary origin of the adaptive immune system--the adipocyte hypothesisGustav van Niekerk, Anna-Mart Engelbrecht
Journal of Toxicology|September 9, 2015
Circadian Rhythms and Breast Cancer: The Role of Per2 in Doxorubicin-Induced Cell DeathMegan I Mitchell, Anna-Mart Engelbrecht
Clinical Nutrition ESPEN|August 28, 2019
Evolutionary physiology shows the need for an unprecedented study on sugarGustav van Niekerk, Anna-Mart Engelbrecht
Frontiers in Microbiology|June 16, 2015
Commentary on: "A common origin for immunity and digestion"Gustav van Niekerk, Anna-Mart Engelbrecht
Cytokine & Growth Factor Reviews|July 5, 2018
Inflammation-induced metabolic derangements or adaptation: An immunometabolic perspectiveGustav van Niekerk, Anna-Mart Engelbrecht
Critical Reviews in Oncology/Hematology|December 25, 2016
Metabolic hijacking: A survival strategy cancer cells exploit?Megan I Mitchell, Anna-Mart Engelbrecht
Cellular Oncology (Dordrecht, Netherlands)|May 26, 2018
Role of PKM2 in directing the metabolic fate of glucose in cancer: a potential therapeutic targetGustav van Niekerk, Anna-Mart Engelbrecht
Future Oncology (London, England)|July 23, 2015
Melatonin: a protective role against doxorubicin-induced cardiotoxicityJenelle Govender, Ben Loos, Anna-Mart Engelbrecht
Cytokine|February 9, 2011
Tumor necrosis factor alpha (TNF-α) inactivates the PI3-kinase/PKB pathway and induces atrophy and apoptosis in L6 myotubesBalindiwe J N Sishi, Anna-Mart Engelbrecht
Pageof 9